By Helgi Analytics - June 22, 2021
Lekarna.cz made a net profit of CZK 7.44 mil with revenues of CZK 720 mil in 2019, up by 191% and up by 38.9%, resp...
By Helgi Analytics - May 6, 2020
Lekarna.cz employed 87.0 employees in 2019, down 5.43% compared to the previous year. Historically, between 2010 and 20...
By Helgi Analytics - June 22, 2021
Lekarna.cz made a net profit of CZK 7.44 mil with revenues of CZK 720 mil in 2019, up by 191% and up by 38.9%, respectively,...
Profit Statement | 2017 | 2018 | 2019 | |
Sales | CZK mil | 510 | 519 | 720 |
Gross Profit | CZK mil | 136 | 136 | 64.6 |
EBITDA | CZK mil | 6.09 | -1.57 | 16.9 |
EBIT | CZK mil | 4.03 | -5.56 | 10.9 |
Financing Cost | CZK mil | 0.517 | 1.18 | 1.21 |
Pre-Tax Profit | CZK mil | 1.99 | -7.56 | 8.23 |
Net Profit | CZK mil | 1.83 | -8.17 | 7.44 |
Balance Sheet | 2017 | 2018 | 2019 | |
Total Assets | CZK mil | 138 | 140 | 160 |
Non-Current Assets | CZK mil | 12.2 | 23.3 | 17.9 |
Current Assets | CZK mil | 120 | 113 | 139 |
Working Capital | CZK mil | 37.9 | 38.0 | 24.3 |
Shareholders' Equity | CZK mil | 31.8 | 23.5 | 31.1 |
Liabilities | CZK mil | 106 | 116 | 129 |
Total Debt | CZK mil | 49.0 | 54.6 | 32.9 |
Net Debt | CZK mil | 25.0 | 27.7 | 1.11 |
Ratios | 2017 | 2018 | 2019 | |
ROE | % | 2.33 | -29.5 | 27.3 |
ROCE | % | 4.25 | -14.7 | 14.4 |
Gross Margin | % | 26.6 | 26.3 | 8.97 |
EBITDA Margin | % | 1.19 | -0.302 | 2.35 |
EBIT Margin | % | 0.789 | -1.07 | 1.51 |
Net Margin | % | 0.359 | -1.57 | 1.03 |
Net Debt/EBITDA | 4.10 | -17.7 | 0.066 | |
Net Debt/Equity | % | 78.4 | 118 | 3.58 |
Cost of Financing | % | 1.28 | 2.28 | 2.76 |
Cash Flow | 2017 | 2018 | 2019 | |
Total Cash From Operations | CZK mil | -13.0 | 4.11 | 26.6 |
Total Cash From Investing | CZK mil | 0.109 | -3.86 | 0.401 |
Total Cash From Financing | CZK mil | 11.7 | 2.60 | -22.2 |
Net Change In Cash | CZK mil | -1.11 | 2.85 | 4.84 |
Cash Conversion Cycle | days | 24.2 | 20.9 | 9.65 |
Cash Earnings | CZK mil | 3.90 | -4.18 | 13.5 |
Free Cash Flow | CZK mil | -12.8 | 0.249 | 27.0 |
Get all company financials in excel:
overview | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
income statement | |||||||||||||||
Sales | CZK mil | 499 | 549 | 474 | 522 | 510 | |||||||||
Gross Profit | CZK mil | 135 | 148 | 137 | 145 | 136 | |||||||||
EBIT | CZK mil | -14.0 | -16.6 | 14.6 | 7.11 | 4.03 | |||||||||
Net Profit | CZK mil | -15.4 | -5.08 | 10.5 | 3.24 | 1.83 | |||||||||
ROE | % | ... | -37.8 | -20.8 | 14.3 | 2.59 | 2.33 | ||||||||
EBIT Margin | % | -2.81 | -3.02 | 3.09 | 1.36 | 0.789 | |||||||||
Net Margin | % | -3.08 | -0.926 | 2.21 | 0.620 | 0.359 | |||||||||
Employees | ... | ... | ... | ... | 125 | 130 | 86.0 | 83.6 | 90.0 | ||||||
balance sheet | |||||||||||||||
Total Assets | CZK mil | 139 | 86.7 | 125 | 125 | 138 | |||||||||
Non-Current Assets | CZK mil | 16.5 | 7.40 | 8.64 | 11.1 | 12.2 | |||||||||
Current Assets | CZK mil | 122 | 79.1 | 116 | 109 | 120 | |||||||||
Shareholders' Equity | CZK mil | 27.6 | 21.3 | 125 | 125 | 31.8 | |||||||||
Liabilities | CZK mil | 112 | 65.4 | 0 | 0 | 106 | |||||||||
Non-Current Liabilities | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Current Liabilities | CZK mil | 78.6 | 53.2 | 86.4 | 79.1 | 91.0 | |||||||||
Net Debt/EBITDA | 0.312 | -0.202 | 0.115 | 0.754 | 4.10 | ||||||||||
Net Debt/Equity | % | -13.9 | 14.6 | 1.42 | 5.10 | 78.4 | |||||||||
Cost of Financing | % | ... | ... | ... | ... | ... | ... | 2.08 | 2.87 | 2.72 | 1.54 | 1.28 | |||
cash flow | |||||||||||||||
Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -0.562 | -13.0 | ||
Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -3.75 | 0.109 | ||
Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0.201 | 11.7 | ||
Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -4.11 | -1.11 |
income statement | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
income statement | |||||||||||||||
Sales | CZK mil | 499 | 549 | 474 | 522 | 510 | |||||||||
Cost of Goods & Services | CZK mil | 364 | 401 | 337 | 377 | 375 | |||||||||
Gross Profit | CZK mil | 135 | 148 | 137 | 145 | 136 | |||||||||
Staff Cost | CZK mil | 59.8 | 64.1 | 45.3 | 44.6 | 52.2 | |||||||||
EBITDA | CZK mil | -12.3 | -15.4 | 15.4 | 8.46 | 6.09 | |||||||||
Depreciation | CZK mil | 1.73 | 1.19 | 0.770 | 1.35 | 2.06 | |||||||||
EBIT | CZK mil | -14.0 | -16.6 | 14.6 | 7.11 | 4.03 | |||||||||
Net Financing Cost | CZK mil | 1.22 | 2.39 | 1.43 | 2.29 | -2.04 | |||||||||
Financing Cost | CZK mil | 0.449 | 0.513 | 0.559 | 0.483 | 0.517 | |||||||||
Financing Income | CZK mil | 0.025 | 0.033 | 0.207 | 0.080 | 0.267 | |||||||||
Pre-Tax Profit | CZK mil | -15.4 | -4.66 | 13.2 | 4.82 | 1.99 | |||||||||
Tax | CZK mil | 0 | 0.420 | 2.73 | 1.59 | 0.159 | |||||||||
Minorities | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Net Profit | CZK mil | -15.4 | -5.08 | 10.5 | 3.24 | 1.83 | |||||||||
Net Profit Avail. to Common | CZK mil | -15.4 | -5.08 | 10.5 | 3.24 | 1.83 | |||||||||
growth rates | |||||||||||||||
Total Revenue Growth | % | ... | 16.5 | 9.96 | -13.7 | 10.1 | -2.19 | ||||||||
Staff Cost Growth | % | ... | 15.0 | 7.15 | -29.3 | -1.57 | 17.1 | ||||||||
EBITDA Growth | % | ... | -504 | 25.2 | -200 | -45.1 | -28.0 | ||||||||
EBIT Growth | % | ... | -1,162 | 18.2 | -188 | -51.4 | -43.4 | ||||||||
Pre-Tax Profit Growth | % | ... | 723 | -69.7 | -383 | -63.5 | -58.7 | ||||||||
Net Profit Growth | % | ... | 678 | -66.9 | -306 | -69.1 | -43.4 | ||||||||
ratios | |||||||||||||||
ROE | % | ... | -37.8 | -20.8 | 14.3 | 2.59 | 2.33 | ||||||||
ROA | % | ... | -10.7 | -4.50 | 9.89 | 2.59 | 1.39 | ||||||||
ROCE | % | ... | -26.8 | -12.0 | 36.3 | 9.89 | 4.25 | ||||||||
Gross Margin | % | 27.0 | 27.0 | 28.9 | 27.7 | 26.6 | |||||||||
EBITDA Margin | % | -2.46 | -2.80 | 3.25 | 1.62 | 1.19 | |||||||||
EBIT Margin | % | -2.81 | -3.02 | 3.09 | 1.36 | 0.789 | |||||||||
Net Margin | % | -3.08 | -0.926 | 2.21 | 0.620 | 0.359 | |||||||||
Cost of Financing | % | ... | ... | ... | ... | ... | ... | 2.08 | 2.87 | 2.72 | 1.54 | 1.28 | |||
Net Debt/EBITDA | 0.312 | -0.202 | 0.115 | 0.754 | 4.10 |
balance sheet | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
balance sheet | |||||||||||||||
Cash & Cash Equivalents | CZK mil | 29.5 | 6.90 | 29.3 | 25.2 | 24.0 | |||||||||
Receivables | CZK mil | 47.4 | 41.3 | 43.6 | 46.2 | 49.3 | |||||||||
Inventories | CZK mil | 30.1 | 14.9 | 23.1 | 19.3 | 30.6 | |||||||||
Current Assets | CZK mil | 122 | 79.1 | 116 | 109 | 120 | |||||||||
Property, Plant & Equipment | CZK mil | 11.1 | 1.20 | 1.81 | 0.878 | 1.34 | |||||||||
LT Investments & Receivables | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Intangible Assets | CZK mil | 0.536 | 2.40 | 4.48 | 7.48 | 9.03 | |||||||||
Goodwill | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Non-Current Assets | CZK mil | 16.5 | 7.40 | 8.64 | 11.1 | 12.2 | |||||||||
Total Assets | CZK mil | 139 | 86.7 | 125 | 125 | 138 | |||||||||
Trade Payables | CZK mil | 37.5 | 35.3 | 46.0 | 40.5 | 42.0 | |||||||||
Short-Term Debt | CZK mil | 25.7 | 10.0 | 31.1 | 31.6 | 49.0 | |||||||||
Other ST Liabilities | CZK mil | 15.5 | 7.89 | 9.30 | 7.02 | -0.014 | |||||||||
Current Liabilities | CZK mil | 78.6 | 53.2 | 86.4 | 79.1 | 91.0 | |||||||||
Long-Term Debt | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Other LT Liabilities | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Non-Current Liabilities | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Liabilities | CZK mil | 112 | 65.4 | 0 | 0 | 106 | |||||||||
Equity Before Minority Interest | CZK mil | 27.6 | 21.3 | 125 | 125 | 31.8 | |||||||||
Minority Interest | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||
Equity | CZK mil | 27.6 | 21.3 | 125 | 125 | 31.8 | |||||||||
growth rates | |||||||||||||||
Total Asset Growth | % | ... | -6.61 | -37.7 | 44.2 | 0.097 | 9.99 | ||||||||
Shareholders' Equity Growth | % | ... | -48.5 | -22.9 | 487 | 0.097 | -74.6 | ||||||||
Net Debt Growth | % | ... | -30.6 | -181 | -42.7 | 259 | 291 | ||||||||
Total Debt Growth | % | ... | ... | ... | ... | ... | ... | ... | 46.9 | -61.1 | 211 | 1.58 | 55.1 | ||
ratios | |||||||||||||||
Total Debt | CZK mil | 25.7 | 10.0 | 31.1 | 31.6 | 49.0 | |||||||||
Net Debt | CZK mil | -3.83 | 3.10 | 1.78 | 6.38 | 25.0 | |||||||||
Working Capital | CZK mil | 40.1 | 20.9 | 20.7 | 24.9 | 37.9 | |||||||||
Capital Employed | CZK mil | 56.6 | 28.3 | 29.4 | 36.0 | 50.2 | |||||||||
Net Debt/Equity | % | -13.9 | 14.6 | 1.42 | 5.10 | 78.4 | |||||||||
Current Ratio | 1.55 | 1.49 | 1.34 | 1.38 | 1.32 | ||||||||||
Quick Ratio | 0.979 | 0.905 | 0.844 | 0.902 | 0.806 |
cash flow | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
cash flow | |||||||||||||||
Net Profit | CZK mil | -15.4 | -5.08 | 10.5 | 3.24 | 1.83 | |||||||||
Depreciation | CZK mil | 1.73 | 1.19 | 0.770 | 1.35 | 2.06 | |||||||||
Non-Cash Items | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -0.962 | -3.83 | ||
Change in Working Capital | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -4.19 | -13.0 | ||
Total Cash From Operations | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -0.562 | -13.0 | ||
Capital Expenditures | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -3.85 | -4.97 | ||
Other Investing Activities | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0.099 | 5.08 | ||
Total Cash From Investing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -3.75 | 0.109 | ||
Dividends Paid | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | -5.42 | ||
Issuance Of Shares | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | ||
Issuance Of Debt | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0.490 | 17.2 | ||
Total Cash From Financing | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0.201 | 11.7 | ||
Effect of FX Rates | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | ||
Net Change In Cash | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -4.11 | -1.11 | ||
ratios | |||||||||||||||
Days Sales Outstanding | days | 34.7 | 27.4 | 33.6 | 32.3 | 35.3 | |||||||||
Days Sales Of Inventory | days | 30.2 | 13.6 | 25.0 | 18.6 | 29.8 | |||||||||
Days Payable Outstanding | days | 37.5 | 32.2 | 49.8 | 39.2 | 40.9 | |||||||||
Cash Conversion Cycle | days | 27.3 | 8.88 | 8.83 | 11.7 | 24.2 | |||||||||
Cash Earnings | CZK mil | -13.6 | -3.89 | 11.2 | 4.59 | 3.90 | |||||||||
Free Cash Flow | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -4.31 | -12.8 | ||
Capital Expenditures (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0.738 | 0.973 |
other ratios | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
Employees | ... | ... | ... | ... | 125 | 130 | 86.0 | 83.6 | 90.0 | ||||||
Cost Per Employee | USD per month | ... | ... | ... | ... | 2,039 | 1,923 | 1,840 | 1,763 | 2,059 | ... | ||||
Cost Per Employee (Local Currency) | CZK per month | ... | ... | ... | ... | 39,891 | 41,097 | 43,913 | 44,471 | 48,355 | |||||
Staff Cost (As % of Sales) | % | 12.0 | 11.7 | 9.56 | 8.55 | 10.2 | |||||||||
Effective Tax Rate | % | 0 | -9.01 | 20.7 | 32.9 | 7.99 | |||||||||
Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 18.8 | 17.2 | 10.4 | 7.72 | 3.56 | ||||
Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 18.7 | 13.2 |
Get all company financials in excel:
By Helgi Analytics - June 22, 2021
Lekarna.cz made a net profit of CZK 7.44 mil in 2019, up 191% compared to the previous year. Historically, between 2006 and 2019, the company's net profit reached a high of CZK 16.1 mil in 2010 and a low of CZK -15.4 mil in 2013. The result implies a retu...
By Helgi Analytics - June 22, 2021
Lekarna.cz's net debt stood at CZK 1.11 mil and accounted for 3.58% of equity at the end of 2019. The ratio is down 114 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 118% in 2018 and a low of ...
Lekarna.cz is a Czech-based online pharmacy owned by Pears Health Cyber. The Company was set up by Vladimír Finsterle in 1999 as an information portal about medications. In 2003, the Company turned into an e-shop and become the first online pharmacy in the Czech Republic.
Lekarna.cz has been growing its sales by 5.59% a year on average in the last 5 years. EBITDA has grown by 210% during that time to total of CZK 16.9 mil in 2019, or 2.35% of sales. That’s compared to 1.62% average margin seen in last five years.
The company netted CZK 7.44 mil in 2019 implying ROE of 27.3% and ROCE of 14.4%. Again, the average figures were 3.39% and 10.0%, respectively when looking at the previous 5 years.
Lekarna.cz’s net debt amounted to CZK 1.11 mil at the end of 2019, or 3.58% of equity. When compared to EBITDA, net debt was 0.066x, up when compared to average of -2.53x seen in the last 5 years.